BioScrip (BIOS) Misses Q2 EPS by 5c
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
BioScrip (NASDAQ: BIOS) reported Q2 EPS of ($0.14), $0.05 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $232.5 million versus the consensus estimate of $229.58 million.
BioScrip sees FY2016 EPS of ($0.48)-($0.38).
For earnings history and earnings-related data on BioScrip (BIOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Dorian LPG (LPG) Posts Light Q2 Results
- Forum Energy Technologies (FET) Misses Q3 EPS by 1c
- Pebblebrook Hotel Trust (PEB) Tops Q3 AFFO by 6c
Create E-mail Alert Related CategoriesEarnings, Guidance
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!